Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,429,571 papers from all fields of science
Search
Sign In
Create Free Account
Scleroderma
Known as:
Progressive systemic scleroderma
, Dermatosclerosis
, Scleroderma (Disease)
Expand
A localized or systemic chronic and progressive autoimmune disorder characterized by thickening of the skin and the connective tissues. Localized…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
12 relations
Autoimmune Diseases
CREST Syndrome
Classical phenylketonuria
Collagen Diseases
Expand
Broader (2)
Connective Tissue Diseases
Dermatologic disorders
Narrower (1)
Localized scleroderma
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Effect of mast cell chymase inhibitor on the development of scleroderma in tight‐skin mice
N. Shiota
,
E. Kakizoe
,
K. Shimoura
,
Tetsuya Tanaka
,
H. Okunishi
British Journal of Pharmacology
2005
Corpus ID: 19211255
1 Although the pathogenesis of scleroderma is not fully understood, activation of connective‐tissue‐type mast cells (CTMCs) has…
Expand
2003
2003
The roles of Transforming growth Factor Type β3(TGF-β3) and mast cells in the pathogenesis of scleroderma
M. K. Ozbilgin
,
S. Inan
Clinical Rheumatology
2003
Corpus ID: 13257994
Scleroderma is a connective tissue disorder characterised by excessive accumulation of collagen in the skin and internal organs…
Expand
2002
2002
Nine‐year follow‐up of a case of Grzybowski type multiple keratoacanthomas and failure to demonstrate human papillomavirus
Norbert Haas
,
Dirk Schadendorf
,
B. M. Henz
,
Pawel G. Fuchs
British Journal of Dermatology
2002
Corpus ID: 35739810
Summary We describe a patient with a 9‐year history of generalized eruptive keratoacanthoma (KA) of the Grzybowski type whose…
Expand
1995
1995
Is it possible to reduce observer variability in skin score assessment of scleroderma? The ad hoc International Group on the Assessment of Disease Outcome in Scleroderma.
A. Silman
,
M. Harrison
,
P. Brennan
Journal of Rheumatology
1995
Corpus ID: 10082218
OBJECTIVE A total skin thickness score based on summating the numerical severity grade at a specific number of skin sites is a…
Expand
Highly Cited
1994
Highly Cited
1994
Treatment of localised scleroderma with PUVA bath photochemotherapy
M. Kerscher
,
M. Volkenandt
,
M. Meurer
,
P. Lehmann
,
G. Plewig
,
M. Röcken
The Lancet
1994
Corpus ID: 43778902
1990
1990
Sparing effect of hemiplegia on scleroderma.
S. Sethi
,
W. Sequeira
Annals of the Rheumatic Diseases
1990
Corpus ID: 45250894
The paretic limb is spared in patients who develop rheumatic diseases after a hemiplegic stroke. This has been described…
Expand
1985
1985
Sclerodermoid changes of porphyria cutanea tarda: possible relationship to urinary uroporphyrin levels.
Stephen J. Friedman
,
John A. Doyle
Journal of American Academy of Dermatology
1985
Corpus ID: 4872449
1966
1966
Carpal tunnel syndrome in dermatomyositis and scleroderma.
C. Quiñones
,
H. Perry
,
J. G. Rushton
Archives of Dermatology
1966
Corpus ID: 6400532
The carpal tunnel syndrome, although a well-defined clinical entity, has been appreciated only recently as a manifestation of…
Expand
Review
1963
Review
1963
MELORHEOSTOSIS WITH LINEAR SCLERODERMA.
S. Muller
,
E. D. Henderson
Archives of Dermatology
1963
Corpus ID: 43780675
The seventh case of linear scleroderma associated with melorheostosis is presented and the literature reviewed. Melorheostosis is…
Expand
1951
1951
Chronic scleroderma with acute exacerbation during corticotropin therapy; report of a case with autopsy observations.
J. Lunseth
,
L. Baker
,
A. Shifrin
A M A Archives of Internal Medicine
1951
Corpus ID: 43571166
IT HAS been established that scleroderma is a generalized disease. The condition usually runs a chronic course, but it may become…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE